|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.640 HKD | -1.48% |
|
-7.39% | +31.49% |
Company Valuation: Alibaba Health Information Technology Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,49,895 | 55,546 | 67,155 | 47,224 | 70,650 | 95,979 | - | - |
| Change | - | -77.77% | 20.9% | -29.68% | 49.61% | 35.85% | - | - |
| Enterprise Value (EV) 1 | 2,38,259 | 45,133 | 56,315 | 37,753 | 62,849 | 84,666 | 81,685 | 78,257 |
| Change | - | -81.06% | 24.78% | -32.96% | 66.47% | 34.71% | -3.52% | -4.2% |
| P/E ratio | 708x | -209x | 126x | 46.8x | 49.5x | 40.4x | 33.8x | 29x |
| PBR | 17.2x | 3.93x | 4.43x | 2.83x | 4.33x | 5.12x | 4.46x | 3.85x |
| PEG | - | 1x | -0x | 0.8x | 1.2x | 0.6x | 1.7x | 1.8x |
| Capitalization / Revenue | 16.1x | 2.7x | 2.51x | 1.75x | 2.31x | 2.72x | 2.44x | 2.23x |
| EV / Revenue | 15.4x | 2.19x | 2.1x | 1.4x | 2.05x | 2.4x | 2.08x | 1.82x |
| EV / EBITDA | 529x | -43.7x | 1,764x | 54.4x | 40.9x | 35.4x | 28.2x | 22.7x |
| EV / EBIT | 539x | -41.2x | -1,772x | 59x | 42.5x | 36.1x | 28.5x | 22.7x |
| EV / FCF | 246x | 110x | 225x | 35.7x | - | 33.6x | 28x | 22x |
| FCF Yield | 0.41% | 0.91% | 0.44% | 2.8% | - | 2.98% | 3.57% | 4.55% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.0262 | -0.0197 | 0.0394 | 0.0627 | 0.0888 | 0.1468 | 0.1756 | 0.2046 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 15,518 | 20,578 | 26,763 | 27,027 | 30,598 | 35,243 | 39,291 | 43,109 |
| EBITDA 1 | 450.2 | -1,034 | 31.93 | 693.9 | 1,536 | 2,395 | 2,899 | 3,443 |
| EBIT 1 | 442.1 | -1,094 | -31.79 | 640.2 | 1,479 | 2,346 | 2,870 | 3,448 |
| Net income 1 | 348.6 | -265.6 | 533.4 | 883.5 | 1,432 | 2,309 | 2,758 | 3,237 |
| Net Debt 1 | -11,637 | -10,412 | -10,839 | -9,471 | -7,801 | -11,313 | -14,294 | -17,722 |
| Reference price 2 | 18.541 | 4.112 | 4.970 | 2.937 | 4.393 | 5.938 | 5.938 | 5.938 |
| Nbr of stocks (in thousands) | 1,34,77,663 | 1,35,07,505 | 1,35,11,061 | 1,60,81,435 | 1,60,82,550 | 1,61,64,466 | - | - |
| Announcement Date | 25/05/21 | 25/05/22 | 23/05/23 | 27/05/24 | 19/05/25 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 41.05x | 2.44x | 35.96x | -.--% | 1.4TCr | ||
| 36.4x | 2.14x | 34.6x | -.--% | 2.67TCr | ||
| 17.23x | 0.78x | 7.89x | 1.93% | 629.59Cr | ||
| 21.48x | 1.39x | 9.77x | 3.04% | 471.72Cr | ||
| 16.06x | 1.02x | 7.25x | 2.62% | 392.1Cr | ||
| 19.29x | 0.75x | 6.37x | 2.82% | 325.03Cr | ||
| 14.73x | 1.33x | 7.93x | 5.74% | 323.1Cr | ||
| Average | 23.75x | 1.41x | 15.68x | 2.31% | 886.85Cr | |
| Weighted average by Cap. | 31.06x | 1.83x | 25.72x | 1.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 241 Stock
- Valuation Alibaba Health Information Technology Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















